VMP 16671111000001106

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Noradrenaline (base) 4mg/4ml solution for infusion ampoules
BNF code 0207020R0AAAFAF
Virtual Therapeutic Moiety Noradrenaline
Basis of preferred name BAN - British Approved Name
Date of name applicability 20 Aug 2010
Previous name Noradrenaline 8mg/4ml solution for infusion ampoules
Basis of previous name BAN - British Approved Name
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 4.000
Unit dose form units ml
Unit dose unit of measure ampoule
Virtual Product Ingredient
Ingredient Noradrenaline acid tartrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 45555007
Strength value numerator 1.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Dose Form
Formulation Solution for infusion
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Noradrenaline (base) 4mg/4ml concentrate for solution for infusion ampoules (Aguettant Ltd)
Noradrenaline (base) 4mg/4ml concentrate for solution for infusion ampoules (AS Kalceks)
Noradrenaline (base) 4mg/4ml concentrate for solution for infusion ampoules (Fresenius Kabi Ltd)
Noradrenaline (base) 4mg/4ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd)
Noradrenaline (base) 4mg/4ml concentrate for solution for infusion ampoules (Pfizer Ltd)
Virtual Medicinal Product Packs
Noradrenaline (base) 4mg/4ml solution for infusion ampoules 10 ampoule
Noradrenaline (base) 4mg/4ml solution for infusion ampoules 5 ampoule

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.

Feedback